Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.

Source:http://linkedlifedata.com/resource/pubmed/id/19264769

Download in:

View as

General Info

PMID
19264769